Literature DB >> 21176865

Evaluation of three novel azasterols against Toxoplasma gondii.

Erica S Martins-Duarte1, Leandro Lemgruber, Silvia Orenes Lorente, Ludovic Gros, Filippo Magaraci, Ian H Gilbert, Wanderley de Souza, Rossiane C Vommaro.   

Abstract

Previous studies from our group have demonstrated the high susceptibility of Toxoplasma gondii tachyzoites to the sterol analogues 22,26-azasterol and 24,25-(R,S)-epiminolanosterol. In this work we present data on testing in vitro three novel azasterols as potential agents for the treatment of toxoplasmosis. The three compounds inhibited parasite growth at micromolar concentrations, in a dose-dependent manner. Electron microscopy analysis of intracellular tachyzoites after treatment with the most effective compound showed drastic mitochondrion swelling associated with the appearance of an electron-lucent matrix and disrupted cristae. Parasite lysis also took place. The appearance of electron dense cytoplasmic structures similar to amylopectin granules distributed throughout the parasite suggests that azasterols might be inducing differentiation of those tachyzoites which were not lysed to the bradyzoite stage.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21176865     DOI: 10.1016/j.vetpar.2010.11.034

Source DB:  PubMed          Journal:  Vet Parasitol        ISSN: 0304-4017            Impact factor:   2.738


  8 in total

1.  Reduction of Toxoplasma gondii Development Due to Inhibition of Parasite Antioxidant Enzymes by a Dinuclear Iron(III) Compound.

Authors:  J A Portes; T G Souza; T A T dos Santos; L L R da Silva; T P Ribeiro; M D Pereira; A Horn; C Fernandes; R A DaMatta; W de Souza; S H Seabra
Journal:  Antimicrob Agents Chemother       Date:  2015-09-21       Impact factor: 5.191

Review 2.  Review of Experimental Compounds Demonstrating Anti-Toxoplasma Activity.

Authors:  Madalyn M McFarland; Sydney J Zach; Xiaofang Wang; Lakshmi-Prasad Potluri; Andrew J Neville; Jonathan L Vennerstrom; Paul H Davis
Journal:  Antimicrob Agents Chemother       Date:  2016-11-21       Impact factor: 5.191

Review 3.  Targeting lipid biosynthesis and salvage in apicomplexan parasites for improved chemotherapies.

Authors:  Isabelle Coppens
Journal:  Nat Rev Microbiol       Date:  2013-10-28       Impact factor: 60.633

4.  A new iron(III) complex-containing sulfadiazine inhibits the proliferation and induces cystogenesis of Toxoplasma gondii.

Authors:  Juliana de A Portes; Nathália F B Azeredo; Pedro G T Siqueira; Tatiana Guinancio de Souza; Christiane Fernandes; Adolfo Horn; Dalber R S Candela; Wanderley de Souza; Renato A DaMatta; Sérgio H Seabra
Journal:  Parasitol Res       Date:  2018-06-22       Impact factor: 2.289

5.  Enrofloxacin and Toltrazuril Are Able to Reduce Toxoplasma gondii Growth in Human BeWo Trophoblastic Cells and Villous Explants from Human Third Trimester Pregnancy.

Authors:  Rafaela J da Silva; Angelica O Gomes; Priscila S Franco; Ariane S Pereira; Iliana C B Milian; Mayara Ribeiro; Paolo Fiorenzani; Maria C Dos Santos; José R Mineo; Neide M da Silva; Eloisa A V Ferro; Bellisa de Freitas Barbosa
Journal:  Front Cell Infect Microbiol       Date:  2017-07-26       Impact factor: 5.293

Review 6.  A Systematic Review of In vitro and In vivo Activities of Anti-Toxoplasma Drugs and Compounds (2006-2016).

Authors:  Mahbobeh Montazeri; Mehdi Sharif; Shahabeddin Sarvi; Saeed Mehrzadi; Ehsan Ahmadpour; Ahmad Daryani
Journal:  Front Microbiol       Date:  2017-01-20       Impact factor: 5.640

7.  Identification of potential dual -targets anti- toxoplasma gondii compounds through structure-based virtual screening and in-vitro studies.

Authors:  Nurul Hanim Salin; Rahmah Noordin; Belal O Al-Najjar; Ezatul Ezleen Kamarulzaman; Muhammad Hafiznur Yunus; Izzati Zahidah Abdul Karim; Nurul Nadieya Mohd Nasim; Iffah Izzati Zakaria; Habibah A Wahab
Journal:  PLoS One       Date:  2020-05-22       Impact factor: 3.240

8.  Design, Synthesis, and Evaluation of a Luminescent Cholesterol Mimic.

Authors:  Emily M Work; Guillermo Ferraudi; Luke Kiefer; Gang Liu; Michael Grigalunas; Atul Bhardwaj; Rasmin Kaur; Janel M Dempsey; Daniel Wüstner; Paul Helquist; Olaf Wiest
Journal:  J Org Chem       Date:  2020-12-28       Impact factor: 4.354

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.